Former Names B6.129P2-Ptprca Igh-Vtm1Mnz/J (Changed: 11-JUL-07 ) Type Congenic; Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Additional information on Congenic nomenclature. Species laboratory mouse Generation N?pN1
Generation DefinitionsDonating Investigator Michel Nussenzweig, The Rockefeller University Description
Mice homozygous for this targeted mutation are viable and fertile and do not display any gross physical or behavioral abnormalities. In combination with immunoglobulin lambda light chain, this heavy chain variable (V) region produces antibody that binds hapten NP (4-hydroxy-3-nitrophenylacetyl). A Trp to Leu point mutation at codon 33 results in a 40-fold increase in antigen binding affinity (B1-8hi). Despite the significantly enhanced affinity for NP, there is only a 2-3 fold difference in the T-independent proliferative response of B cells that carry high or low affinity receptors. In T cell-dependent responses there is no difference in the ability of B1-8 high vs. B1-8 low affinity cells to enter germinal center reactions. However, high affinity B cells were recruited preferentially in response to both T cell-dependent and T cell-independent antigens. Expression has been verified by immunostaining cells that carry the mutation.Development
PCR was used to introduce a point mutation conferring higher affinity 4-hydroxy-3-nitrophenyl)acetyl (NP)-binding to Igh (VHB1-8): TGG->TTG (codon 33 Trp->Leu). A targeting vector incorporating a 5' floxed neomycin cassette in addition to the point mutation was transfected into 129P2/OlaHsd-derived E14 embryonic stem (ES) cells. Positive clones were injected into C57BL/6 blastocysts, and the resulting chimeric males were bred to C57BL/6 EIIA-Cre females to delete the neomycin gene, and leave a loxP site. Mice were backcrossed to C57BL/6 congenic background CD45.1 (Ptprca) mice for at least 12 generations by the donating laboratory.
Strains carrying Ightm1Mnz allele
007775 CBy.129P2(B6)-Ightm1Mnz/J View Strains carrying Ightm1Mnz (1 strain)
Strains carrying Ptprca allele
008451 B6.129P(Cg)-Ptprca Cx3cr1tm1Litt/LittJ 006259 B6.Cg-Pepcb Ptprca Tg(UBC-scFv)2Nemz/J 013198 B6.Cg-Ptprca Mir223tm1Fcam/J 002014 B6.SJL-Ptprca Pepcb/BoyJ 018869 C.129S4(Cg)-Il13tm2.1Lky/J 006584 CBy.SJL(B6)-Ptprca/J View Strains carrying Ptprca (6 strains)
Strains carrying other alleles of Igh
012642 B6.129P2(C)-Ightm2Cgn/J 007776 B6.129P2-Ightm2Mnz/J 001317 B6.Cg-Igha Thy1a Gpi1a/J 011074 C.129P2(B6)-Igktm1Rsky Ightm2Rsky/PldJ 012235 C.129P2(B6)-Igktm2Rsky Ightm2Rsky/J 008332 C.129S1-Ightm1(Myc)Janz/J 001109 C.AL-Igho/SmnJ 001107 C.BKa-Ighb/IcrSmnJ 004126 C.Cg-Cd19tm1(cre)Cgn Ighb/J View Strains carrying other alleles of Igh (9 strains)
Strains carrying other alleles of Ptprc
007172 129S6.129X1(B6)-Ptprctm1Weis/J 002725 B6.129-Ptprctm1Holm/J 007171 B6.129X1-Ptprctm1Weis/J 017351 BKa.Cg-Ptprcb Bmi1tm1Ilw Thy1a/J 007687 BKa.Cg-Sox17tm1Sjm Ptprcb Thy1a/J 007686 BKa.Cg-Sox17tm2Sjm Ptprcb Thy1a/J 007173 C.129X1(B6)-Ptprctm1Weis/J 016091 C57BL/6-Ptprcltng/J 014149 NOD.B6-Ptprcb/6908MrkTacJ 005616 NOD.C-(Ptprc-D1Mit262)/WehiJ View Strains carrying other alleles of Ptprc (10 strains)
View Related Disease (OMIM) Terms
Related Disease (OMIM) Terms provided by MGI
- Potential model based on gene homology relationships. Phenotypic similarity to the human disease has not been tested. Hepatitis C Virus, Susceptibility to (PTPRC)
Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Positive, Nk Cell-Positive (PTPRC)
View Mammalian Phenotype Terms
Mammalian Phenotype Terms provided by MGI
assigned by genotype
Ightm1Mnz/Ightm1Mnz
B6.129P2-Ightm1Mnz
- immune system phenotype
- abnormal B cell physiology
- some mutant B cells that express Ig lambda differentiate into short-lived plasmacytes in red pulp of lymphoid follicles; plasmacyte response is greater than in Ightm2Mnz cells or wild-type (MGI Ref ID J:75653)
- fraction of mutant B cells differentiate into short lived germinal center (GC) cells; GC response is greater than in Ightm2Mnz cells (MGI Ref ID J:75653)
- when equal numbers of Ightm1Mnz and Ightm2Mnz B cells are transferred to wild-type recipient mice, after immunization with NP-Ficoll, Ightm1Mnz B cells preferentially expand and proliferation to make up ~46% of Ig lambda B cells whereas Ightm2Mnz B cells are not expanded (MGI Ref ID J:75653)
- after 5 days post immunization, 85% of plasmacytes and 60% of germinal center cells are Ightm1Mnz B cells (high affinity) (MGI Ref ID J:75653)
- mutant B cells with high affinity for antigen are preferentially selected during early phase of T1-2 immune response, over mutant B cells with low affinity for antigen (MGI Ref ID J:75653)
- increased B cell apoptosis
- there are higher numbers of apoptotic mutant B cells than in wild-type or Ightm2Mnz B cells in spleens 3 and 5 days after immunization (MGI Ref ID J:75653)
- increased B cell proliferation
- mutant B cells in mice challenged with a T1-2 antigen (NP-Ficoll) undergo rapid proliferative expansion (from 3 to 25% of lymphocytes by 5 days after immunization (MGI Ref ID J:75653)
- in immunized mice, on day 2 there is a much higher percentage of high-affinity B cells (58%) compared to wild-type cells (~3%) (MGI Ref ID J:75653)
- increased IgG level
- 4-hydroxy-3-nitrophenyl)acetyl-specific (NP) IgM antibody production is greater than in Ightm2Mnz B cells or wild-type (MGI Ref ID J:75653)
- increased IgM level
- NP-specific IgM antibody production is greater than in Ightm2Mnz B cells or wild-type (MGI Ref ID J:75653)
- cellular phenotype
- abnormal cell cycle
- absolute number of cells in cell cycle is always higher than in Ightm2Mnz or wild-type mice (MGI Ref ID J:75653)
- increased B cell apoptosis
- there are higher numbers of apoptotic mutant B cells than in wild-type or Ightm2Mnz B cells in spleens 3 and 5 days after immunization (MGI Ref ID J:75653)
- increased B cell proliferation
- mutant B cells in mice challenged with a T1-2 antigen (NP-Ficoll) undergo rapid proliferative expansion (from 3 to 25% of lymphocytes by 5 days after immunization (MGI Ref ID J:75653)
- in immunized mice, on day 2 there is a much higher percentage of high-affinity B cells (58%) compared to wild-type cells (~3%) (MGI Ref ID J:75653)
- hematopoietic system phenotype
- increased B cell proliferation
- mutant B cells in mice challenged with a T1-2 antigen (NP-Ficoll) undergo rapid proliferative expansion (from 3 to 25% of lymphocytes by 5 days after immunization (MGI Ref ID J:75653)
- in immunized mice, on day 2 there is a much higher percentage of high-affinity B cells (58%) compared to wild-type cells (~3%) (MGI Ref ID J:75653)
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
| Allele Symbol | Ightm1Mnz | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Michel C Nussenzweig | ||
| Allele Type | Targeted (knock-in) | ||
| Common Name(s) | B1-8hi; | ||
| Mutation Made By | Michel Nussenzweig, The Rockefeller University | ||
| Strain of Origin | 129P2/OlaHsd | ||
| ES Cell Line Name | E14 | ||
| ES Cell Line Strain | 129P2/OlaHsd | ||
| Promoter | Igh, immunoglobulin heavy chain complex, mouse, laboratory | ||
| Molecular Note | PCR was used to introduce a point mutation conferring higher affinity 4-hydroxy-3-nitrophenyl)acetyl (NP)-binding to Igh-V (VHB1-8): TGG->TTG (codon 33 Trp->Leu). A targeting vector incorporating a 5' floxed neomycin cassette in addition to the point mutation was transfected into 129P2/OlaHsd-derived E14 embryonic stem (ES) cells. [MGI Ref ID J:75653] | ||
| Allele Symbol | Ptprca | ||
| Allele Name | a variant | ||
| Allele Type | Not Applicable | ||
| Common Name(s) | CD45.1; Ly5a; PtprcSJL; | ||
| Gene Symbol and Name | Ptprc, protein tyrosine phosphatase, receptor type, C | ||
| Chromosome | 1 | ||
| Gene Common Name(s) | B220; CD45; CD45 antigen; CD45R; Cd45; GP180; L-CA; LCA; LY5; Ly-5; Lyt-4; RT7; T-lymphocyte antigen 4; T200; lymphocyte antigen 5; | ||
| Molecular Note |
Ptprca is found in strains SJL/J, STS/A, and DA. Ptprcb is found in strains C57BL/6, C3H/An, DBA/2, AKR, and many others (J:13367, J:12054, J:12077, J:8603). Twelve nucleotide differences between the a and b alleles have been identified. These base substitutions correspond to five amino-acid changes within the extracellular domain of the encoded protein. These amino-acid differences are clustered in a region that also contains the greatest divergence between mouse and rat sequences (J:22485). Note that the allele designations originally described were reversed in 1987 (J:8603); all publications prior to 1987 show SJL/J, STS/A, and DA as having the b allele and the C57BL/6J group as having the a allele (J:22341). [MGI Ref ID J:12548] [MGI Ref ID J:22485] [MGI Ref ID J:8080] | ||
Genotyping Protocols
Ightm1Mnz, High Resolution Melting
Ightm1Mnz, Standard PCR
Helpful Links
Genotyping resources and troubleshooting
Shih TA; Roederer M; Nussenzweig MC. 2002. Role of antigen receptor affinity in T cell-independent antibody responses in vivo. Nat Immunol 3(4):399-406. [PubMed: 11896394] [MGI Ref ID J:75653]
Ightm1Mnz relatedPtprca relatedAiba Y; Kometani K; Hamadate M; Moriyama S; Sakaue-Sawano A; Tomura M; Luche H; Fehling HJ; Casellas R; Kanagawa O; Miyawaki A; Kurosaki T. 2010. Preferential localization of IgG memory B cells adjacent to contracted germinal centers. Proc Natl Acad Sci U S A 107(27):12192-7. [PubMed: 20547847] [MGI Ref ID J:162089]
Cadera EJ; Wan F; Amin RH; Nolla H; Lenardo MJ; Schlissel MS. 2009. NF-kappaB activity marks cells engaged in receptor editing. J Exp Med 206(8):1803-16. [PubMed: 19581408] [MGI Ref ID J:151490]
Chappell CP; Draves KE; Giltiay NV; Clark EA. 2012. Extrafollicular B cell activation by marginal zone dendritic cells drives T cell-dependent antibody responses. J Exp Med 209(10):1825-40. [PubMed: 22966002] [MGI Ref ID J:191423]
Crouch EE; Li Z; Takizawa M; Fichtner-Feigl S; Gourzi P; Montano C; Feigenbaum L; Wilson P; Janz S; Papavasiliou FN; Casellas R. 2007. Regulation of AID expression in the immune response. J Exp Med 204(5):1145-56. [PubMed: 17452520] [MGI Ref ID J:125740]
Dominguez-Sola D; Victora GD; Ying CY; Phan RT; Saito M; Nussenzweig MC; Dalla-Favera R. 2012. The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry. Nat Immunol 13(11):1083-91. [PubMed: 23001145] [MGI Ref ID J:188565]
Draghi NA; Denzin LK. 2010. H2-O, a MHC class II-like protein, sets a threshold for B-cell entry into germinal centers. Proc Natl Acad Sci U S A 107(38):16607-12. [PubMed: 20807742] [MGI Ref ID J:164357]
Kamphorst AO; Guermonprez P; Dudziak D; Nussenzweig MC. 2010. Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes. J Immunol 185(6):3426-35. [PubMed: 20729332] [MGI Ref ID J:163535]
King IL; Fortier A; Tighe M; Dibble J; Watts GF; Veerapen N; Haberman AM; Besra GS; Mohrs M; Brenner MB; Leadbetter EA. 2011. Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent manner. Nat Immunol 13(1):44-50. [PubMed: 22120118] [MGI Ref ID J:178990]
Kitano M; Moriyama S; Ando Y; Hikida M; Mori Y; Kurosaki T; Okada T. 2011. Bcl6 protein expression shapes pre-germinal center B cell dynamics and follicular helper T cell heterogeneity. Immunity 34(6):961-72. [PubMed: 21636294] [MGI Ref ID J:174014]
Mohr E; Cunningham AF; Toellner KM; Bobat S; Coughlan RE; Bird RA; MacLennan IC; Serre K. 2010. IFN-{gamma} produced by CD8 T cells induces T-bet-dependent and -independent class switching in B cells in responses to alum-precipitated protein vaccine. Proc Natl Acad Sci U S A 107(40):17292-7. [PubMed: 20855629] [MGI Ref ID J:165414]
Ouchida R; Kurosaki T; Wang JY. 2010. A role for lysosomal-associated protein transmembrane 5 in the negative regulation of surface B cell receptor levels and B cell activation. J Immunol 185(1):294-301. [PubMed: 20519653] [MGI Ref ID J:161622]
Reina-San-Martin B; Difilippantonio S; Hanitsch L; Masilamani RF; Nussenzweig A; Nussenzweig MC. 2003. H2AX is required for recombination between immunoglobulin switch regions but not for intra-switch region recombination or somatic hypermutation. J Exp Med 197(12):1767-78. [PubMed: 12810694] [MGI Ref ID J:120658]
Robbiani DF; Bunting S; Feldhahn N; Bothmer A; Camps J; Deroubaix S; McBride KM; Klein IA; Stone G; Eisenreich TR; Ried T; Nussenzweig A; Nussenzweig MC. 2009. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol Cell 36(4):631-41. [PubMed: 19941823] [MGI Ref ID J:154731]
Schwickert TA; Alabyev B; Manser T; Nussenzweig MC. 2009. Germinal center reutilization by newly activated B cells. J Exp Med 206(13):2907-14. [PubMed: 19934021] [MGI Ref ID J:155831]
Serre K; Cunningham AF; Coughlan RE; Lino AC; Rot A; Hub E; Moser K; Manz R; Ferraro A; Bird R; Toellner KM; Demengeot J; MacLennan IC; Mohr E. 2012. CD8 T cells induce T-bet-dependent migration toward CXCR3 ligands by differentiated B cells produced during responses to alum-protein vaccines. Blood 120(23):4552-9. [PubMed: 23065152] [MGI Ref ID J:190901]
Victora GD; Schwickert TA; Fooksman DR; Kamphorst AO; Meyer-Hermann M; Dustin ML; Nussenzweig MC. 2010. Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter. Cell 143(4):592-605. [PubMed: 21074050] [MGI Ref ID J:166836]
Ashbaugh JJ; Brambilla R; Karmally SA; Cabello C; Malek TR; Bethea JR. 2013. IL7Ralpha Contributes to Experimental Autoimmune Encephalomyelitis through Altered T Cell Responses and Nonhematopoietic Cell Lineages. J Immunol 190(9):4525-34. [PubMed: 23530149] [MGI Ref ID J:195519]
Basu S; Ray A; Dittel BN. 2011. Cannabinoid receptor 2 is critical for the homing and retention of marginal zone B lineage cells and for efficient T-independent immune responses. J Immunol 187(11):5720-32. [PubMed: 22048769] [MGI Ref ID J:179699]
Cho RH; Sieburg HB; Muller-Sieburg CE. 2008. A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells. Blood 111(12):5553-61. [PubMed: 18413859] [MGI Ref ID J:162992]
Coleman MA; Bridge JA; Lane SW; Dixon CM; Hill GR; Wells JW; Thomas R; Steptoe RJ. 2013. Tolerance induction with gene-modified stem cells and immune-preserving conditioning in primed mice: restricting antigen to differentiated antigen-presenting cells permits efficacy. Blood 121(6):1049-58. [PubMed: 23233664] [MGI Ref ID J:194614]
De Santo C; Arscott R; Booth S; Karydis I; Jones M; Asher R; Salio M; Middleton M; Cerundolo V. 2010. Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A. Nat Immunol 11(11):1039-46. [PubMed: 20890286] [MGI Ref ID J:166540]
Del Cid N; Shen L; Belleisle J; Raghavan M. 2012. Assessment of roles for calreticulin in the cross-presentation of soluble and bead-associated antigens. PLoS One 7(7):e41727. [PubMed: 22848581] [MGI Ref ID J:189698]
Ewald SJ; McKenzie IFC. 1979. Immunochemical characterization of the Ly-5 alloantigens on thymocytes. Immunogenetics 8:583-587. [MGI Ref ID J:13367]
Gardam S; Turner VM; Anderton H; Limaye S; Basten A; Koentgen F; Vaux DL; Silke J; Brink R. 2011. Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response. Blood 117(15):4041-51. [PubMed: 21300983] [MGI Ref ID J:172843]
Gerloff J; Korshunov VA. 2012. Immune modulation of vascular resident cells by axl orchestrates carotid intima-media thickening. Am J Pathol 180(5):2134-43. [PubMed: 22538191] [MGI Ref ID J:183990]
Glass AM; Wolf BJ; Schneider KM; Princiotta MF; Taffet SM. 2013. Connexin43 is dispensable for phagocytosis. J Immunol 190(9):4830-5. [PubMed: 23554311] [MGI Ref ID J:195494]
Harp JA; Davis BS; Ewald SJ. 1984. Inhibition of T cell responses to alloantigens and polyclonal mitogens by Ly-5 antisera. J Immunol 133(1):10-5. [PubMed: 6233370] [MGI Ref ID J:7453]
Held W; Clevers H; Grosschedl R. 2003. Redundant functions of TCF-1 and LEF-1 during T and NK cell development, but unique role of TCF-1 for Ly49 NK cell receptor acquisition. Eur J Immunol 33(5):1393-8. [PubMed: 12731066] [MGI Ref ID J:85394]
Hirahara K; Ghoreschi K; Yang XP; Takahashi H; Laurence A; Vahedi G; Sciume G; Hall AO; Dupont CD; Francisco LM; Chen Q; Tanaka M; Kanno Y; Sun HW; Sharpe AH; Hunter CA; O'Shea JJ. 2012. Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1. Immunity 36(6):1017-30. [PubMed: 22726954] [MGI Ref ID J:187415]
Huber S; Hoffmann R; Muskens F; Voehringer D. 2010. Alternatively activated macrophages inhibit T-cell proliferation by Stat6-dependent expression of PD-L2. Blood 116(17):3311-20. [PubMed: 20625006] [MGI Ref ID J:165869]
Iijima N; Mattei LM; Iwasaki A. 2011. Recruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissue. Proc Natl Acad Sci U S A 108(1):284-9. [PubMed: 21173243] [MGI Ref ID J:169008]
Janowska-Wieczorek A; Majka M; Kijowski J; Baj-Krzyworzeka M; Reca R; Turner AR; Ratajczak J; Emerson SG; Kowalska MA; Ratajczak MZ. 2001. Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood 98(10):3143-9. [PubMed: 11698303] [MGI Ref ID J:109863]
Jiang S; Alberich-Jorda M; Zagozdzon R; Parmar K; Fu Y; Mauch P; Banu N; Makriyannis A; Tenen DG; Avraham S; Groopman JE; Avraham HK. 2011. Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization. Blood 117(3):827-38. [PubMed: 21063029] [MGI Ref ID J:168507]
Kasai M; Leclerc JC; Shen FW; Cantor H. 1979. Identification of Ly 5 on the surface of `natural killer' cells in normal and athymic inbred mouse strains. Immunogenetics 8:153-159. [MGI Ref ID J:12054]
Kitano M; Moriyama S; Ando Y; Hikida M; Mori Y; Kurosaki T; Okada T. 2011. Bcl6 protein expression shapes pre-germinal center B cell dynamics and follicular helper T cell heterogeneity. Immunity 34(6):961-72. [PubMed: 21636294] [MGI Ref ID J:174014]
Komuro K ; Itakura K ; Boyse EA ; John M. 1975. Ly-5: a new lymphocyte antigen system. Immunogenetics 1:452-456. [MGI Ref ID J:12077]
Leskov IL; Whitsett J; Vasquez-Vivar J; Stokes KY. 2011. NAD(P)H oxidase and eNOS play differential roles in cytomegalovirus infection-induced microvascular dysfunction. Free Radic Biol Med 51(12):2300-8. [PubMed: 22033010] [MGI Ref ID J:179407]
Masson F; Minnich M; Olshansky M; Bilic I; Mount AM; Kallies A; Speed TP; Busslinger M; Nutt SL; Belz GT. 2013. Id2-Mediated Inhibition of E2A Represses Memory CD8+ T Cell Differentiation. J Immunol 190(9):4585-94. [PubMed: 23536629] [MGI Ref ID J:195516]
McAleer JP; Liu B; Li Z; Ngoi SM; Dai J; Oft M; Vella AT. 2010. Potent intestinal Th17 priming through peripheral lipopolysaccharide-based immunization. J Leukoc Biol 88(1):21-31. [PubMed: 20130220] [MGI Ref ID J:162449]
McNally A; Hill GR; Sparwasser T; Thomas R; Steptoe RJ. 2011. CD4+CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2 homeostasis. Proc Natl Acad Sci U S A 108(18):7529-34. [PubMed: 21502514] [MGI Ref ID J:172217]
Meisner JK; Song J; Price RJ. 2012. Arteriolar and venular remodeling are differentially regulated by bone marrow-derived cell-specific CX3CR1 and CCR2 expression. PLoS One 7(9):e46312. [PubMed: 23029475] [MGI Ref ID J:191962]
Mobraaten LE. 1994. Ly5 gene nomenclature, C57BL/6J and SJL/J - A history of change JAX Notes Summer(458):2. [MGI Ref ID J:22341]
Moebius J; van den Broek M; Groettrup M; Basler M. 2010. Immunoproteasomes are essential for survival and expansion of T cells in virus-infected mice. Eur J Immunol 40(12):3439-49. [PubMed: 21108466] [MGI Ref ID J:174578]
Morse HC 3rd; Shen FW; Hammerling U. 1987. Genetic nomenclature for loci controlling mouse lymphocyte antigens. Immunogenetics 25(2):71-8. [PubMed: 3817907] [MGI Ref ID J:8603]
Muller AJ; Filipe-Santos O; Eberl G; Aebischer T; Spath GF; Bousso P. 2012. CD4+ T cells rely on a cytokine gradient to control intracellular pathogens beyond sites of antigen presentation. Immunity 37(1):147-57. [PubMed: 22727490] [MGI Ref ID J:187413]
Nobrega C; Nunes-Alves C; Cerqueira-Rodrigues B; Roque S; Barreira-Silva P; Behar SM; Correia-Neves M. 2013. T cells home to the thymus and control infection. J Immunol 190(4):1646-58. [PubMed: 23315077] [MGI Ref ID J:193323]
Pepper M; Pagan AJ; Igyarto BZ; Taylor JJ; Jenkins MK. 2011. Opposing signals from the bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells. Immunity 35(4):583-95. [PubMed: 22018468] [MGI Ref ID J:177635]
Pulliam-Leath AC; Ciccone SL; Nalepa G; Li X; Si Y; Miravalle L; Smith D; Yuan J; Li J; Anur P; Orazi A; Vance GH; Yang FC; Hanenberg H; Bagby GC; Clapp DW. 2010. Genetic disruption of both Fancc and Fancg in mice recapitulates the hematopoietic manifestations of Fanconi anemia. Blood 116(16):2915-20. [PubMed: 20606166] [MGI Ref ID J:165874]
Raschke WC; Hendricks M; Chen CM. 1995. Genetic basis of antigenic differences between three alleles of Ly5 (CD45) in mice. Immunogenetics 41(2-3):144-7. [PubMed: 7806287] [MGI Ref ID J:22485]
Robbins CS; Chudnovskiy A; Rauch PJ; Figueiredo JL; Iwamoto Y; Gorbatov R; Etzrodt M; Weber GF; Ueno T; van Rooijen N; Mulligan-Kehoe MJ; Libby P; Nahrendorf M; Pittet MJ; Weissleder R; Swirski FK. 2012. Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation 125(2):364-74. [PubMed: 22144566] [MGI Ref ID J:193795]
Roman E; Shino H; Qin FX; Liu YJ. 2010. Cutting edge: Hematopoietic-derived APCs select regulatory T cells in thymus. J Immunol 185(7):3819-23. [PubMed: 20802149] [MGI Ref ID J:164214]
Schluns KS; Williams K; Ma A; Zheng XX; Lefrancois L. 2002. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J Immunol 168(10):4827-31. [PubMed: 11994430] [MGI Ref ID J:109854]
Seldin MF; D'Hoostelaere LA; Steinberg AD; Saga Y; Morse HC 3rd. 1987. Allelic variants of Ly-5 in inbred and natural populations of mice. Immunogenetics 26(1-2):74-8. [PubMed: 2886425] [MGI Ref ID J:8805]
Shang X; Cancelas JA; Li L; Guo F; Liu W; Johnson JF; Ficker A; Daria D; Geiger H; Ratner N; Zheng Y. 2011. R-Ras and Rac GTPase cross-talk regulates hematopoietic progenitor cell migration, homing, and mobilization. J Biol Chem 286(27):24068-78. [PubMed: 21572048] [MGI Ref ID J:175297]
Shen FW; Saga Y; Litman G; Freeman G; Tung JS; Cantor H; Boyse EA. 1985. Cloning of Ly-5 cDNA. Proc Natl Acad Sci U S A 82(21):7360-3. [PubMed: 3864163] [MGI Ref ID J:8080]
Shen FW; Tung JS; Boyse EA. 1986. Further definition of the Ly-5 system. Immunogenetics 24(3):146-9. [PubMed: 3489673] [MGI Ref ID J:8430]
Shulzhenko N; Morgun A; Matzinger P. 2009. Spontaneous mutation in the Cd79b gene leads to a block in B-lymphocyte development at the C' (early pre-B) stage. Genes Immun 10(8):722-6. [PubMed: 19727123] [MGI Ref ID J:157450]
Siggs OM; Arnold CN; Huber C; Pirie E; Xia Y; Lin P; Nemazee D; Beutler B. 2011. The P4-type ATPase ATP11C is essential for B lymphopoiesis in adult bone marrow. Nat Immunol 12(5):434-40. [PubMed: 21423172] [MGI Ref ID J:171925]
Silva DG; Daley SR; Hogan J; Lee SK; Teh CE; Hu DY; Lam KP; Goodnow CC; Vinuesa CG. 2011. Anti-islet autoantibodies trigger autoimmune diabetes in the presence of an increased frequency of islet-reactive CD4 T cells. Diabetes 60(8):2102-11. [PubMed: 21788582] [MGI Ref ID J:186792]
So T; Soroosh P; Eun SY; Altman A; Croft M. 2011. Antigen-independent signalosome of CARMA1, PKC{theta}, and TNF receptor-associated factor 2 (TRAF2) determines NF-{kappa}B signaling in T cells. Proc Natl Acad Sci U S A 108(7):2903-8. [PubMed: 21282629] [MGI Ref ID J:169068]
Sun S; Xia S; Ji Y; Kersten S; Qi L. 2012. The ATP-P2X7 signaling axis is dispensable for obesity-associated inflammasome activation in adipose tissue. Diabetes 61(6):1471-8. [PubMed: 22415881] [MGI Ref ID J:196855]
Tadagavadi RK; Reeves WB. 2010. Renal dendritic cells ameliorate nephrotoxic acute kidney injury. J Am Soc Nephrol 21(1):53-63. [PubMed: 19875815] [MGI Ref ID J:185867]
Teng EC; Racioppi L; Means AR. 2011. A cell-intrinsic role for CaMKK2 in granulocyte lineage commitment and differentiation. J Leukoc Biol 90(5):897-909. [PubMed: 21816924] [MGI Ref ID J:178260]
Waterstrat A; Liang Y; Swiderski CF; Shelton BJ; Van Zant G. 2010. Congenic interval of CD45/Ly-5 congenic mice contains multiple genes that may influence hematopoietic stem cell engraftment. Blood 115(2):408-17. [PubMed: 19901263] [MGI Ref ID J:155980]
Westmuckett AD; Thacker KM; Moore KL. 2011. Tyrosine sulfation of native mouse psgl-1 is required for optimal leukocyte rolling on p-selectin in vivo. PLoS One 6(5):e20406. [PubMed: 21633705] [MGI Ref ID J:172569]
Wingender G; Hiss M; Engel I; Peukert K; Ley K; Haller H; Kronenberg M; von Vietinghoff S. 2012. Neutrophilic granulocytes modulate invariant NKT cell function in mice and humans. J Immunol 188(7):3000-8. [PubMed: 22387552] [MGI Ref ID J:183092]
Yang G; Hisha H; Cui Y; Fan T; Jin T; Li Q; Lian Z; Hosaka N; Li Y; Ikehara S. 2002. A new assay method for late CFU-S formation and long-term reconstituting activity using a small number of pluripotent hemopoietic stem cells. Stem Cells 20(3):241-8. [PubMed: 12004082] [MGI Ref ID J:109853]
Yeager AM; Shinn C; Shinohara M; Pardoll DM. 1993. Hematopoietic cell transplantation in the twitcher mouse. The effects of pretransplant conditioning with graded doses of busulfan. Transplantation 56(1):185-90. [PubMed: 8101401] [MGI Ref ID J:14381]
Zebedee SL; Barritt DS; Raschke WC. 1991. Comparison of mouse Ly5a and Ly5b leucocyte common antigen alleles. Dev Immunol 1(4):243-54. [PubMed: 1822988] [MGI Ref ID J:12548]
de Andres-Aguayo L; Varas F; Kallin EM; Infante JF; Wurst W; Floss T; Graf T. 2011. Musashi 2 is a regulator of the HSC compartment identified by a retroviral insertion screen and knockout mice. Blood 118(3):554-64. [PubMed: 21613258] [MGI Ref ID J:174870]
Animal Health Reports
Production of mice from cryopreserved embryos or sperm occurs in a maximum barrier room, G200.
| Pricing for USA, Canada and Mexico shipping destinations |
|
Cryopreserved Mice - Ready for Recovery
Animals Provided
Price (US dollars $) Cryorecovery* $2085.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
Standard Supply
Cryopreserved. Ready for recovery. Please refer to pricing and supply notes on the strain data sheet for further information.
Supply Notes
Cryorecovery - Standard.
Progeny testing is not required.
The average number of mice provided from recovery of our cryopreserved strains is 10. The total number of animals provided, their gender and genotype will vary. We will fulfill your order by providing at least two pair of mice, at least one animal of each pair carrying the mutation of interest. Please inquire if larger numbers of animals with specific genotype and genders are needed. Animals typically ship between 11 and 14 weeks from the date of your order. If a second cryorecovery is needed in order to provide the minimum number of animals, animals will ship within 25 weeks. IMPORTANT NOTE: The genotypes of animals provided may not reflect the mating scheme utilized by The Jackson Laboratory prior to cryopreservation, or that discussed in the strain description. Please inquire about possible genotypes which will be recovered for this specific strain. The Jackson Laboratory cannot guarantee the reproductive success of mice shipped to your facility. If the mice are lost after the first three days (post-arrival) or do not produce progeny at your facility, a new order and fee will be necessary.Cryorecovery to establish a Dedicated Supply for greater quantities of mice
Mice recovered can be used to establish a dedicated colony to contractually supply you mice according to your requirements. Price by quotation. For more information on Dedicated Supply, please contact JAX® Services, Tel: 1-800-422-6423 (from U.S.A., Canada or Puerto Rico only) or 1-207-288-5845 (from any location).
| Pricing for International shipping destinations |
|
Cryopreserved Mice - Ready for Recovery
Animals Provided
Price (US dollars $) Cryorecovery* $2710.50 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
Standard Supply
Cryopreserved. Ready for recovery. Please refer to pricing and supply notes on the strain data sheet for further information.
Supply Notes
Cryorecovery - Standard.
Progeny testing is not required.
The average number of mice provided from recovery of our cryopreserved strains is 10. The total number of animals provided, their gender and genotype will vary. We will fulfill your order by providing at least two pair of mice, at least one animal of each pair carrying the mutation of interest. Please inquire if larger numbers of animals with specific genotype and genders are needed. Animals typically ship between 11 and 14 weeks from the date of your order. If a second cryorecovery is needed in order to provide the minimum number of animals, animals will ship within 25 weeks. IMPORTANT NOTE: The genotypes of animals provided may not reflect the mating scheme utilized by The Jackson Laboratory prior to cryopreservation, or that discussed in the strain description. Please inquire about possible genotypes which will be recovered for this specific strain. The Jackson Laboratory cannot guarantee the reproductive success of mice shipped to your facility. If the mice are lost after the first three days (post-arrival) or do not produce progeny at your facility, a new order and fee will be necessary.Cryorecovery to establish a Dedicated Supply for greater quantities of mice
Mice recovered can be used to establish a dedicated colony to contractually supply you mice according to your requirements. Price by quotation. For more information on Dedicated Supply, please contact JAX® Services, Tel: 1-800-422-6423 (from U.S.A., Canada or Puerto Rico only) or 1-207-288-5845 (from any location).
|
|
Cryopreserved. Ready for recovery. Please refer to pricing and supply notes on the strain data sheet for further information.
For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.